United States - English - NLM (National Library of Medicine)

bio-pharm, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

United States - English - NLM (National Library of Medicine)

torrent pharmaceuticals limited - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma. controlled studies have shown that lactulose solution therapy reduces the blood ammonia levels by 25 to 50%; this is generally paralleled by the improvement in the patients’ mental state and by an improvement in eeg patterns. the clinical response has been observed in about 75% of patients, which is at least as satisfactory as that resulting from neomycin therapy. an increase in patients’ protein tolerance is also frequently observed with lactulose therapy. in the treatment of chronic portal-systemic encephalopathy, lactulose has been given for over 2 years in controlled studies. since lactulose solution contains galactose (less than 1.6 g/15 ml) it is contraindicated in patients who require a low galactose diet.

United States - English - NLM (National Library of Medicine)

torrent pharmaceuticals limited - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

United States - English - NLM (National Library of Medicine)

slate run pharmaceuticals llc - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

United States - English - NLM (National Library of Medicine)

lannett company, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

United States - English - NLM (National Library of Medicine)

xttrium laboratories, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

Singapore - English - HSA (Health Sciences Authority)

medicell pharmaceutical (s) pte. ltd. - lactulose syrup (50% w/w) - syrup - 998mg per unit (equivalent to 667mg/ml of lactulose)

Israel - English - Ministry of Health

megapharm ltd - lactulose - solution (oral) - lactulose 670 mg/ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.

United States - English - NLM (National Library of Medicine)

cardinal health 107, llc - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.